Greg Calaman, Rob Friel, Gregory Summe | GenomeWeb
Definiens this week announced that Greg Calaman has been named vice president of its operations in North America. Calaman has been a member of Definiens’ management team since April 2006. 
 
Calaman was previously part of the worldwide IT leadership team at Pfizer. He serves on the Advisory Council of the Krall Center for Executive Education at Drexel University and on the Board of Advisors to the Trestle Group Foundation of London.
 

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.